[1]
|
Spagnolo, P., Distler, O., Ryerson, C.J., et al. (2021) Mechanisms of Progressive Fibrosis in Connective Tissue Disease (CTD)-Associated Interstitial Lung Diseases (ILDs). Annals of the Rheumatic Diseases, 80, 143-150. https://doi.org/10.1136/annrheumdis-2020-217230
|
[2]
|
Joy G.M., Arbiv, O.A., Wong, C.K., et al. (2023) Prevalence, Imaging Patterns and Risk Factors of Interstitial Lung Disease in Connective Tissue Disease: A Systematic Review and Meta-Analysis. European Respiratory Review, 32, Article ID: 220210. https://doi.org/10.1183/16000617.0210-2022
|
[3]
|
Otaki, N., Motomura, Y., Terooatea, T., et al. (1970) Activation of ILC2s through Constitutive IFNγ Signaling Reduction Leads to Spontaneous Pulmonary Fibrosis. Nature Communications, 14, Article No. 8120.
|
[4]
|
Oldham Justin, M., Lee Cathryn, T., Wu, Z., et al. (2022) Lung Function Trajectory in Progressive Fibrosing Interstitial Lung Disease. European Respiratory Journal, 59, Article ID: 2101396. https://doi.org/10.1183/13993003.01396-2021
|
[5]
|
Raghu, G., Remy-Jardin, M., Richeldi, L., et al. (2022) Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine, 205, E18-E47.
|
[6]
|
Wijsenbeek, M., Suzuki, A. and Maher, T.M. (2022) Interstitial Lung Diseases. Lancet, 400, 769-786. https://doi.org/10.1016/S0140-6736(22)01052-2
|
[7]
|
Cerro Chiang, G. and Parimon, T. (2023) Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers. International Journal of Molecular Sciences, 24, Article 2405. https://doi.org/10.3390/ijms24032405
|
[8]
|
Kuwana, M., Bando, M., Kawahito, Y., et al. (2023) Identification and Management of Connective Tissue Disease-Associated Interstitial Lung Disease: Evidence-Based Japanese Consensus Statements. Expert Review of Respiratory Medicine, 17, 71-80. https://doi.org/10.1080/17476348.2023.2176303
|
[9]
|
卢俊慧, 徐浩, 宋远圆, 等. 人血清KL-6对结缔组织病相关间质性肺病诊断价值的研究[J]. 临床肺科杂志, 2017, 22(10): 1806-1808, 1812.
|
[10]
|
朱雪华, 秦亦如, 农骐郢, 等. 血清涎液化糖链抗原6对肺部疾病预警作用研究进展[J]. 中国职业医学, 2023, 50(1): 104-109.
|
[11]
|
刘玉梦, 许爱国, 赵玉苗, 等. 血清KL-6对多发性肌炎/皮肌炎合并肺部疾病的临床价值[J]. 中国实用医刊, 2017, 44(10): 10-12.
|
[12]
|
郑倩倩, 魏小松, 范晓云, 等. 血清KL-6水平与常见结缔组织病并发肺间质病变的关系研究[J]. 安徽医学, 2023, 44(1): 27-31.
|
[13]
|
Lee, J.S., Lee, E.Y., Ha, Y.J., et al. (2019) Serum KL-6 Levels Reflect the Severity of Interstitial Lung Disease Associated with Connective Tissue Disease. Arthritis Research & Therapy, 21, Article No. 58. https://doi.org/10.1186/s13075-019-1835-9
|
[14]
|
吴明福. 不同病程类风湿性关节炎患者IL-6、RF、ASO变化及与其DAS28评分的关联性分析[J]. 医学理论与实践, 2021, 34(16): 2862-2864.
|
[15]
|
Castro, S.V. and Jimenez, S.A. (2010) Biomarkers in Systemic Sclerosis. Biomarkers in Medicine, 4. https://doi.org/10.2217/bmm.09.79
|
[16]
|
Liu, Y.P., Hu, M., Fan, G.Z., et al. (2022) Effect of Baricitinib on the Epithelial-Mesenchymal Transition of Alveolar Epithelial Cells Induced by IL-6. International Immunopharmacology, 110, Article ID: 109044. https://doi.org/10.1016/j.intimp.2022.109044
|
[17]
|
Ma, C.X., Meng, K.F., Shi, S.Y., et al. (2023) Clinical Significance of Interleukin-6, Total Bilirubin, CD3 CD4 T Cells Counts in the Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease: A Cross-Sectional Study. European Journal of Medical Research, 28, Article No. 393. https://doi.org/10.1186/s40001-023-01384-0
|
[18]
|
Lee, J.H., Jang, J.H., Park, J.H., et al. (2021) The Role of Interleukin-6 as a Prognostic Biomarker for Predicting Acute Exacerbation in Interstitial Lung Diseases. PLOS ONE, 16, e0255365. https://doi.org/10.1371/journal.pone.0255365
|
[19]
|
Kim, S.M., Zhao, D., Podolanczuk, A.J., et al. (2018) Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA). The Journal of Nutrition, 148, 1126-1134. https://doi.org/10.1093/jn/nxy066
|
[20]
|
Deng, M., Tang, L., Huang, D., et al. (2018) Vitamin D Deficiency in Connective Tissue Disease-Associated Interstitial Lung Disease. Clinical and Experimental Rheumatology, 36, 1049-1055.
|
[21]
|
Fakhoury, H.M.A., Kvietys, P.R., AlKattan, W., et al. (2020) Vitamin D and Intestinal Homeostasis: Barrier, Microbiota, and Immune Modulation. The Journal of Steroid Biochemistry and Molecular Biology, 200, Article ID: 105663. https://doi.org/10.1016/j.jsbmb.2020.105663
|
[22]
|
Li, S.R., Tan, Z.X., Chen, Y.H., et al. (2019) Vitamin D Deficiency Exacerbates Bleomycin-Induced Pulmonary Fibrosis Partially through Aggravating TGF-β/Smad2/3-Mediated Epithelial-Mesenchymal Transition. Respiratory Research, 20, Article No. 266. https://doi.org/10.1186/s12931-019-1232-6
|
[23]
|
Sherin, H., Dalia, E., Diab, H., et al. (2019) Vitamin D Deficiency and Pulmonary Affection in Rheumatoid Arthritis. Egyptian Journal of Chest Disease and Tuberculosis, 68, 614-623. https://doi.org/10.4103/ejcdt.ejcdt_65_19
|
[24]
|
梁志强. 血清25羟维生素D与皮肌炎相关肺间质病变相关性分析[D]: [硕士学位论文]. 秦皇岛: 华北理工大学, 2019.
|
[25]
|
Gao, Y., Zhao, Q., Qiu, X., et al. (2020) Vitamin D Levels Are Prognostic Factors for Connective Tissue Disease Associated Interstitial Lung Disease (CTD-ILD). Aging, 12, 4371-4378. https://doi.org/10.18632/aging.102890
|
[26]
|
Hu, B., Yang, X.R., Xu, Y., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. https://doi.org/10.1158/1078-0432.CCR-14-0442
|
[27]
|
Liu, B., Wang, J., Li, Y.Y., et al. (2023) The Association between Systemic Immune-Inflammation Index and Rheumatoid Arthritis: Evidence from NHANES 1999-2018. Arthritis Research & Therapy, 25, Article No. 34. https://doi.org/10.1186/s13075-023-03018-6
|
[28]
|
Song, Y.C., Guo, W.C., Li, Z.P., et al. (2022) Systemic Immune-Inflammation Index Is Associated with Hepatic Steatosis: Evidence from NHANES 2015-2018. Frontiers in Immunology, 13, Article 1058779. https://doi.org/10.3389/fimmu.2022.1058779
|
[29]
|
Cao, Y., Li, P.X., Zhang, Y., et al. (2023) Association of Systemic Immune Inflammatory Index with All-Cause and Cause-Specific Mortality in Hypertensive Individuals: Results from NHANES. Frontiers in Immunology, 14, Article 1087345. https://doi.org/10.3389/fimmu.2023.1087345
|
[30]
|
Ding, P.A., Guo, H.H., Sun, C.Y., et al. (2022) Combined Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) Predicts Chemotherapy Response and Prognosis in Locally Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy with PD-1 Antibody Sintilimab and XELOX: A Prospective Study. BMC Gastroenterology, 22, Article No. 121. https://doi.org/10.1186/s12876-022-02199-9
|
[31]
|
Fioranelli, M., Roccia, M.G., Flavin, D. and Cota, L. (2021) Regulation of Inflammatory Reaction in Health and Disease. International Journal of Molecular Sciences, 22, Article 5277. https://doi.org/10.3390/ijms22105277
|
[32]
|
Tanacan, E., Dincer, D., Erdogan, F.G., et al. (2021) A Cutoff Value for the Systemic Immune-Inflammation Index in Determining Activity of Behçet Disease. Clinical and Experimental Dermatology, 46, 286-291. https://doi.org/10.1111/ced.14432
|
[33]
|
Choe, J.Y., Lee, C.U. and Kim, S.K. (2023) Association between Novel Hematological Indices and Measures of Disease Activity in Patients with Rheumatoid Arthritis. Medicina, 59, Article 117. https://doi.org/10.3390/medicina59010117
|
[34]
|
Ruta, V.M., Man, A.M., Alexescu, T.G., et al. (2020) Neutrophil-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease. Medicina, 56, Article 381. https://doi.org/10.3390/medicina56080381
|
[35]
|
Lu, M.J., Gong, L., Huang, C.Y., et al. (2022) Analysis of Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 161 Patients: A Retrospective Study. International Journal of General Medicine, 15, 8617-8625. https://doi.org/10.2147/IJGM.S391146
|
[36]
|
Zhou, P., Shen, Q.X., Zhou, S.T., et al. (2023) The Prognostic Role of C-Reactive Protein to Albumin Ratio and Anti-MDA5 Antibody-Positive in Idiopathic Inflammatory Myopathy: A Retrospective Study. Scientific Reports, 13, Article No. 3863. https://doi.org/10.1038/s41598-023-30595-y
|
[37]
|
Wang, Y.J. and Zhang, Y.M. (2012) Relationship between Hs-CRP、MCP-1、SICAM-1 and Pulse Pressure in Old Patients with Essential Hypertension. Chinese Journal of Clinical Healthcare.
|
[38]
|
Wu, C.Y., Li, L. and Zhang, L.H. (2019) Detection of Serum MCP-1 and TGF-β1 in Polymyositis/Dermatomyositis Patients and Its Significance. European Journal of Medical Research, 24, Article No. 12. https://doi.org/10.1186/s40001-019-0368-7
|
[39]
|
郑云云, 徐文付, 刘进生, 等. 血清IL-6、CAR联合NLR对新生儿呼吸窘迫综合征患儿病情和预后的评估价值[J]. 现代生物医学进展, 2023, 23(7): 1364-1368.
|
[40]
|
王铭, 吕晓雨, 罗雨青, 等. 早期监测PCT、CAR、D-二聚体结合ISS、APACHE II评分对EICU创伤患者预后的评估价值[J]. 临床急诊杂志, 2023, 24(2): 51-57.
|
[41]
|
鲁建亮, 刘梦月. C反应蛋白/白蛋白比值与终末期癌症患者短期预后的关系探讨[J]. 肿瘤基础与临床, 2023, 36(3): 236-240.
|
[42]
|
沈丹凤, 汤晨雪. AAPR、NLR、CAR与原发性肝癌肿瘤包膜侵犯、Ki67指数的相关性及对疾病预后的评估价值[J]. 国际检验医学杂志, 2023, 44(7): 862-865.
|
[43]
|
曹晓宇. 罕见结缔组织疾病临床特征和发病机制的初步探讨[D]: [博士学位论文]. 北京: 中国医学科学院北京协和医学院, 2020.
|
[44]
|
He, Y.J., Tang, J.F., Wu, B.D., et al. (2019) Correlation between Albumin to Fibrinogen Ratio, C-Reactive Protein to Albumin Ratio and Th17 Cells in Patients with Rheumatoid Arthritis. Clinica Chimica Acta, 500, 149-154. https://doi.org/10.1016/j.cca.2019.10.009
|
[45]
|
Ha, Y.J., Hur, J., Jin Go, D., et al. (2018) Baseline Peripheral Blood Neutrophil-to-Lymphocyte Ratio Could Predict Survival in Patients with Adult Polymyositis and Dermatomyositis: A Retrospective Observational Study. PLOS ONE, 13, e0190411. https://doi.org/10.1371/journal.pone.0190411
|
[46]
|
王月. NLR、CAR、PLR和MLR与多发性肌炎/皮肌炎合并间质性肺病疾病活动度相关性及危险因素分析[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2022.
|